Novo Nordisk根据TrumpRx计划,将Ozempic和Wegovy的价格削减为349美元,头两个月为199美元,到2026年3月为止。 Novo Nordisk cuts Ozempic and Wegovy prices to $349/month, $199 for first two months, through March 2026 under TrumpRx program.

Novo Nordisk降低了其GLP-1药物Ozempic和Wegovy的自付费用,从2025年11月17日起,大多数剂量的月价格降至349美元,新患者头两个月有资格每月获得199美元。 Novo Nordisk has reduced the out-of-pocket cost for its GLP-1 drugs Ozempic and Wegovy, lowering monthly prices to $349 for most doses starting November 17, 2025, with new patients eligible for $199 per month for the first two months. 通过药店、远程保健提供者和Costco等零售商提供的折扣,2026年3月31日截止。 The discount, available through pharmacies, telehealth providers, and retailers like Costco, ends March 31, 2026. 这项举措是在与特朗普政府达成通过新的联邦方案 " TrumpRx " 降低价格的更广泛协议之后采取的,目的是改善无保险或保险不足的患者在持续负担能力挑战下获得服务的机会。 The move follows a broader agreement with the Trump administration to lower prices via a new federal program, TrumpRx, and aims to improve access for uninsured or underinsured patients amid ongoing affordability challenges.